2YBP
JMJD2A COMPLEXED WITH R-2-HYDROXYGLUTARATE AND HISTONE H3K36me3 PEPTIDE (30-41)
2YBP の概要
エントリーDOI | 10.2210/pdb2ybp/pdb |
関連するPDBエントリー | 2GF7 2GFA 2GP3 2GP5 2V1D 2VD7 2WWJ 2YBK 2YBS |
分子名称 | LYSINE-SPECIFIC DEMETHYLASE 4A, HISTONE H3.1T, NICKEL (II) ION, ... (7 entities in total) |
機能のキーワード | oxidoreductase-peptide complex, non-heme iron, dioxygenase, double-stranded beta helix, dsbh, facial triad, metal binding protein, epigenetic and transcription regulation, chromatin regulator, hydroxylation, oxidoreductase/peptide |
由来する生物種 | HOMO SAPIENS (HUMAN) 詳細 |
タンパク質・核酸の鎖数 | 4 |
化学式量合計 | 92002.30 |
構造登録者 | |
主引用文献 | Chowdhury, R.,Yeoh, K.K.,Tian, Y.M.,Hillringhaus, L.,Bagg, E.A.,Rose, N.R.,Leung, I.K.,Li, X.S.,Woon, E.C.,Yang, M.,McDonough, M.A.,King, O.N.,Clifton, I.J.,Klose, R.J.,Claridge, T.D.,Ratcliffe, P.J.,Schofield, C.J.,Kawamura, A. The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases. EMBO Rep., 12:463-469, 2011 Cited by PubMed Abstract: Mutations in isocitrate dehydrogenases (IDHs) have a gain-of-function effect leading to R(-)-2-hydroxyglutarate (R-2HG) accumulation. By using biochemical, structural and cellular assays, we show that either or both R- and S-2HG inhibit 2-oxoglutarate (2OG)-dependent oxygenases with varying potencies. Half-maximal inhibitory concentration (IC(50)) values for the R-form of 2HG varied from approximately 25 μM for the histone N(ɛ)-lysine demethylase JMJD2A to more than 5 mM for the hypoxia-inducible factor (HIF) prolyl hydroxylase. The results indicate that candidate oncogenic pathways in IDH-associated malignancy should include those that are regulated by other 2OG oxygenases than HIF hydroxylases, in particular those involving the regulation of histone methylation. PubMed: 21460794DOI: 10.1038/embor.2011.43 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (2.02 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード